Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CPEX shareholders vote for sale
Yahoo/AP
Thursday, March 24, 2011 - 3:17pm
tags:
CPEX Pharmaceuticals, M&A
Sell Pfizer!: Against the Grain (video)
The Street
Thursday, March 24, 2011 - 3:16pm
tags:
Pfizer
Pfizer Drug Slows Pancreatic Tumors in New Attack on Cancer
Bloomberg
Thursday, March 24, 2011 - 3:15pm
tags:
Pfizer, pancreatic cancer, CP- 870, 893, Eli Lilly, Gemzar
Merck returns $50M anti-clotting drug betrixaban to Portola
bizjournals.com
Thursday, March 24, 2011 - 3:14pm
tags:
Merck, betrixaban, Portola Pharmaceuticals, anti-clotting
Watson Launches Generic Famvir
Yahoo/Zacks
Thursday, March 24, 2011 - 3:10pm
tags:
Watson Pharmaceuticals, Famvir, genital herpes, HIV
Pfizer Passes This Key Test
Motley Fool
Thursday, March 24, 2011 - 3:09pm
tags:
Pfizer
China PharmaHub Reviews 2010 and Recent Accomplishments
Yahoo/PR NewsWire
Thursday, March 24, 2011 - 3:08pm
tags:
China PharmaHub
GILD's Elvitegravir Meets Study Goal
Yahoo/Zacks
Thursday, March 24, 2011 - 3:06pm
tags:
Gilead Sciences, elvitegravir, HIV
Targacept drug fails at trial
bizjournals.com
Thursday, March 24, 2011 - 3:04pm
tags:
Targacept, TC-5619, ADHD
Amgen May Be Prepping Dividend
Forbes
Thursday, March 24, 2011 - 3:03pm
tags:
Amgen
Protalix Plans Human Clinical Tests of Medication for Rare Fabry's Disease
Bloomberg
Thursday, March 24, 2011 - 3:00pm
tags:
Protalix BioTherapeutics, Fabry's disease, rheumatoid arthritis, PRX-102, Genzyme, Fabrazyme, Shire, Replagal
Optimer Pharma: Prime Acquisition Target
Seeking Alpha
Thursday, March 24, 2011 - 1:46pm
tags:
Optimer, M&A, antidepressants, Viibryd, fidaxomicin, Clinical Data, Forest Labs
Glaxo Lawyer Says Abbott Tried to Stifle Rivalry on Aids Drug
Bloomberg
Thursday, March 24, 2011 - 1:45pm
tags:
GSK, Abbott Laboratories, AIDS, Norvir
Steere’s Exit Could Mean Pfizer Is Serious About Changing
Forbes
Thursday, March 24, 2011 - 1:44pm
tags:
Pfizer
Sanofi to grow animal health through bolt-on buys
Reuters
Thursday, March 24, 2011 - 1:23pm
tags:
animal health, Sanofi, M&A
Watson Launches Generic Famvir
Yahoo/Zacks.com
Thursday, March 24, 2011 - 12:50pm
tags:
Watson Pharmaceuticals, generics, Famvir, genital herpes, JNJ, Cephalon
J&J’s Ethicon Unit Recalls 360,000 Surgical Drainage Products
Bloomberg
Thursday, March 24, 2011 - 12:45pm
tags:
JNJ, recalls, Ethicon
Targacept drug fails in ADHD midstage study
Yahoo/AP
Thursday, March 24, 2011 - 12:26pm
tags:
Targacept, ADHD, TC-5619
Historical Trial Data Bodes Well for Amarin
Seeking Alpha
Thursday, March 24, 2011 - 12:15pm
tags:
Amarin, AMR101
Titan Pharmaceuticals: Key Catalyst Sneaks Up on Investors
Seeking Alpha
Thursday, March 24, 2011 - 11:50am
tags:
Titan, opiod addiciton, Probuphine

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.